TLDWars
Restricted (85-100%)
- Impact
- 19
Domain Names: * Endovascular.ai
Expiry Date: February 2027/2028
Renewal: registry fees on all
Price: $200,000 BIN (Buy It Now) Minimum Offer: $50,000
Starts: Today @16:00 UK time
A Category Monopoly
The Opportunity:
Own the definitive digital identity for the fastest-growing niche in MedTech. As of March 2026, surgical robotics has moved from "assistive" to "autonomous." Endovascular.ai is the exact-match, high-authority brand for the $130M vascular robotics sector.
Why This Year? (The 2026 Market Context)
The "Blue Ocean": While urology and orthopedics are saturated, Endovascular Robotics is a "Blue Ocean" with minimal competition and a 52% surge in global adoption for cardiovascular/cerebrovascular procedures this year alone.
The AI Precision Era: New 2026 clinical data proves AI-driven robotic surgeries are 40% more accurate than manual techniques, reducing radiation exposure for surgeons by 47%. Endovascular.ai captures this "AI-First" momentum.
M&A Heat: Industry giants like Siemens (Corindus) and Medtronic (Mazor/Affera) have established a precedent for billion-dollar acquisitions in this space. This bundle is designed for a high-value exit.
The Asset Stack: The "Defensive Perimeter" Strategy
We are offering a turnkey brand monopoly. This bundle eliminates your competition before they even start:
Endovascular.ai: The Technical Engine. Positioned as the core AI-navigation platform.
Endovascular.io: The Input/Output Layer. The developer-facing hub for hardware integration.
Endovascular.health: The Clinical Gateway. The patient-facing and hospital-procurement portal.
Endovascular.consulting: The Expertise Layer. For specialized surgeon training and AI-driven diagnostics.
Includes: .app, .co, .cc .si for global trademark protection.
The Valuation Baseline:
Comparison: While generic, condition-based domains like Fibromyalgia.com ($48k) represent static content, Endovascular.ai is a "Generative" asset. It is the infrastructure for a technical platform.
Recent Trends: AI-based surgical robotics is now a $12.91 Billion market in 2026. This domain set places you at the absolute top of the search and brand hierarchy for the most profitable sub-sector.
Terms:
BIN: $200,000 USD (Fixed Price for the Full Set)
Status: Open to serious institutional offers above $50,000.
Escrow: Secure transfer via Escrow.com, Dynadot, GoDaddy, Crypto
#MedTech #Robotics #SurgicalRobotics #AISurgery #Endovascular #DomainBundle #VestedRights #PortfolioLaunch #MedicalAI #BrandMonopoly
"Attention/Tagging Industry Experts:"
@silentg @alimustafa @Acroplex @gagan @Lox @Wolf of DomainStreet. I’m presenting this as a dual-track portfolio (Endovascular + AiEsr). Given your history with premium AI stacks, I’d like your take on the valuation of this unified Surgical Robotics 'Global Shield' in the current 2026 market."
"Private inquiries invited for the complete consolidated portfolio including the AiEsr brand assets."
I am tagging you as leaders in the technical and medical-AI space. Given the massive 2026 expansion of AI-driven surgical navigation and Google's Vertex Healthcare protocols, I'd value your professional perspective on this Endovascular brand stack.
- Endovascular.io
- Endovascular.health
- Endovascular.consulting
- Endovascular.app
- Endovascular.co
- Endovascular.cc
- Endovascular.si
Expiry Date: February 2027/2028
Renewal: registry fees on all
Price: $200,000 BIN (Buy It Now) Minimum Offer: $50,000
Starts: Today @16:00 UK time
A Category Monopoly
The Opportunity:
Own the definitive digital identity for the fastest-growing niche in MedTech. As of March 2026, surgical robotics has moved from "assistive" to "autonomous." Endovascular.ai is the exact-match, high-authority brand for the $130M vascular robotics sector.
Why This Year? (The 2026 Market Context)
The "Blue Ocean": While urology and orthopedics are saturated, Endovascular Robotics is a "Blue Ocean" with minimal competition and a 52% surge in global adoption for cardiovascular/cerebrovascular procedures this year alone.
The AI Precision Era: New 2026 clinical data proves AI-driven robotic surgeries are 40% more accurate than manual techniques, reducing radiation exposure for surgeons by 47%. Endovascular.ai captures this "AI-First" momentum.
M&A Heat: Industry giants like Siemens (Corindus) and Medtronic (Mazor/Affera) have established a precedent for billion-dollar acquisitions in this space. This bundle is designed for a high-value exit.
The Asset Stack: The "Defensive Perimeter" Strategy
We are offering a turnkey brand monopoly. This bundle eliminates your competition before they even start:
Endovascular.ai: The Technical Engine. Positioned as the core AI-navigation platform.
Endovascular.io: The Input/Output Layer. The developer-facing hub for hardware integration.
Endovascular.health: The Clinical Gateway. The patient-facing and hospital-procurement portal.
Endovascular.consulting: The Expertise Layer. For specialized surgeon training and AI-driven diagnostics.
Includes: .app, .co, .cc .si for global trademark protection.
The Valuation Baseline:
Comparison: While generic, condition-based domains like Fibromyalgia.com ($48k) represent static content, Endovascular.ai is a "Generative" asset. It is the infrastructure for a technical platform.
Recent Trends: AI-based surgical robotics is now a $12.91 Billion market in 2026. This domain set places you at the absolute top of the search and brand hierarchy for the most profitable sub-sector.
Terms:
BIN: $200,000 USD (Fixed Price for the Full Set)
Status: Open to serious institutional offers above $50,000.
Escrow: Secure transfer via Escrow.com, Dynadot, GoDaddy, Crypto
#MedTech #Robotics #SurgicalRobotics #AISurgery #Endovascular #DomainBundle #VestedRights #PortfolioLaunch #MedicalAI #BrandMonopoly
"Attention/Tagging Industry Experts:"
@silentg @alimustafa @Acroplex @gagan @Lox @Wolf of DomainStreet. I’m presenting this as a dual-track portfolio (Endovascular + AiEsr). Given your history with premium AI stacks, I’d like your take on the valuation of this unified Surgical Robotics 'Global Shield' in the current 2026 market."
"Private inquiries invited for the complete consolidated portfolio including the AiEsr brand assets."
I am tagging you as leaders in the technical and medical-AI space. Given the massive 2026 expansion of AI-driven surgical navigation and Google's Vertex Healthcare protocols, I'd value your professional perspective on this Endovascular brand stack.
Attachments
Last edited:














